JP2017516772A5 - - Google Patents

Download PDF

Info

Publication number
JP2017516772A5
JP2017516772A5 JP2016568812A JP2016568812A JP2017516772A5 JP 2017516772 A5 JP2017516772 A5 JP 2017516772A5 JP 2016568812 A JP2016568812 A JP 2016568812A JP 2016568812 A JP2016568812 A JP 2016568812A JP 2017516772 A5 JP2017516772 A5 JP 2017516772A5
Authority
JP
Japan
Prior art keywords
dodeca
oxo
triazatricyclo
trifluoromethyl
tetraen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016568812A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017516772A (ja
JP6580074B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2015/061468 external-priority patent/WO2015177367A1/en
Publication of JP2017516772A publication Critical patent/JP2017516772A/ja
Publication of JP2017516772A5 publication Critical patent/JP2017516772A5/ja
Application granted granted Critical
Publication of JP6580074B2 publication Critical patent/JP6580074B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016568812A 2014-05-23 2015-05-22 S100阻害薬として有用な新規化合物 Expired - Fee Related JP6580074B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14169757.3 2014-05-23
EP14169757 2014-05-23
PCT/EP2015/061468 WO2015177367A1 (en) 2014-05-23 2015-05-22 Novel compounds useful as s100-inhibitors

Publications (3)

Publication Number Publication Date
JP2017516772A JP2017516772A (ja) 2017-06-22
JP2017516772A5 true JP2017516772A5 (enExample) 2018-05-10
JP6580074B2 JP6580074B2 (ja) 2019-09-25

Family

ID=50774707

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016568812A Expired - Fee Related JP6580074B2 (ja) 2014-05-23 2015-05-22 S100阻害薬として有用な新規化合物

Country Status (12)

Country Link
US (1) US9771372B2 (enExample)
EP (1) EP2991990B1 (enExample)
JP (1) JP6580074B2 (enExample)
KR (1) KR20170005868A (enExample)
CN (1) CN106414448B (enExample)
AU (1) AU2015261775B2 (enExample)
BR (1) BR112016024749A2 (enExample)
CA (1) CA2948436A1 (enExample)
EA (1) EA030604B1 (enExample)
ES (1) ES2620751T3 (enExample)
MX (1) MX2016014483A (enExample)
WO (1) WO2015177367A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11858984B2 (en) 2018-04-27 2024-01-02 National University Corporation Okayama University Anti-S100A8/A9 antibody and use thereof
US11197908B2 (en) 2018-07-17 2021-12-14 The Board Of Trustees Of The University Of Arkansas Peptoids and methods for attenuating inflammatory response
US20230144545A1 (en) 2019-10-30 2023-05-11 National University Corporation Okayama University Prophylactic and/or therapeutic agent for inflammatory pulmonary disease
WO2023209141A1 (en) 2022-04-29 2023-11-02 Westfälische Wilhelms-Universität Münster Benzo[d]imidazo[1,2-a]imidazoles and their use in diagnosis
WO2025132458A1 (en) 2023-12-18 2025-06-26 Chiesi Farmaceutici S.P.A. Pyridazinyl amino derivatives as alk5 inhibitors

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6248755B1 (en) 1999-04-06 2001-06-19 Merck & Co., Inc. Pyrrolidine modulators of chemokine receptor activity
AR029489A1 (es) 2000-03-10 2003-07-02 Euro Celtique Sa Piridinas, pirimidinas, pirazinas, triazinas sustituidas por arilo, composiciones farmaceuticas y el uso de las mismas para la manufactura de un medicamento
US7361678B2 (en) * 2002-03-05 2008-04-22 Transtech Pharma, Inc. Azole derivatives and fused bicyclic azole derivatives as therapeutic agents
AU8974901A (en) 2000-07-26 2002-02-05 Smithkline Beecham Plc Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity
CN1235583C (zh) * 2001-03-05 2006-01-11 特兰斯泰克制药公司 用作治疗剂的苯并咪唑衍生物
GB0117506D0 (en) 2001-07-18 2001-09-12 Bayer Ag Imidazopyridinones
SE0104331D0 (sv) 2001-12-19 2001-12-19 Astrazeneca Ab Novel compounds
US20060111416A1 (en) 2004-11-24 2006-05-25 Lane Charlotte A L Octahydropyrrolo[3,4-C]pyrrole derivatives
JP2010504980A (ja) 2006-09-28 2010-02-18 エグゼリクシス, インコーポレイテッド Jak−2モジュレーターおよび使用方法
WO2008118454A2 (en) 2007-03-23 2008-10-02 Amgen Inc. Derivatives of quinoline or benzopyrazine and their uses for the treatment of (inter alia) inflammatory diseases, autoimmune diseases or various kinds of cancer
EP1986009A1 (en) * 2007-04-26 2008-10-29 Active Biotech AB Screening method
CN101977505A (zh) 2007-06-13 2011-02-16 葛兰素史密丝克莱恩有限责任公司 类法尼醇x受体激动剂
US8901141B2 (en) * 2008-01-22 2014-12-02 Takeda Pharmaceutical Company, Limited Tricyclic compounds having corticotropin-releasing factor antagonistic activity and pharmaceutical compositions containing them
TW201004941A (en) 2008-07-16 2010-02-01 Wyeth Corp Alpha7 nicotinic acetylcholine receptor inhibitors
BRPI1011477A2 (pt) 2009-03-02 2016-03-22 Sirtris Pharmaceuticals Inc quinolinas 8-substituidas e analogos relacionados como moduladores de sirtuina
MX2014005285A (es) 2011-11-03 2014-05-30 Hoffmann La Roche Compuestos biciclicos de piperazina.
GB201321728D0 (en) * 2013-12-09 2014-01-22 Ucb Pharma Sa Therapeutic agents

Similar Documents

Publication Publication Date Title
JP2019077725A5 (enExample)
JP4638355B2 (ja) チアゾール誘導体
JP2016523911A5 (enExample)
JP2017530185A5 (enExample)
IL258577A (en) 2,4-dihydroxy-nicotinamides as apj agonists
JP2018524343A5 (enExample)
JP2018530591A5 (enExample)
HRP20201469T1 (hr) Derivati tetrahidroizokinolina
JP2016517878A5 (enExample)
JP2017516772A5 (enExample)
JP2019519484A5 (enExample)
RU2016141646A (ru) Ингибиторы trka киназы, основанные на них композиции и способы
RU2012143794A (ru) Производные n-(имидазопиримидин-7-ил)-гетероаламидов и их применение в качестве ингибиторов pde10a
RU2018123779A (ru) Новые соединения
JP2011503166A5 (enExample)
JP2012532931A5 (enExample)
RU2016102137A (ru) Первичные карбоксамиды в качестве ингибиторов bik
JP2017512794A5 (enExample)
RU2017121044A (ru) Производные амидотиадиазола в качестве ингибиторов надфн-оксидазы
RU2019132212A (ru) Селективные ингибиторы hdac6
RU2012134306A (ru) Азотосодержащие производные гетероарилов
CA2610888A1 (en) Inhibitors of akt activity
RU2013145299A (ru) Тиазолопиримидины
JP2017508766A5 (enExample)
JP2017512786A (ja) TrkAキナーゼ阻害薬、その組成物および方法